Figure 10 — Identification and validation of a novel signature based on macrophage marker genes for predicting prognosis and drug response in kidney renal clear cell carcinoma by integrated analysis of single cell and bulk RNA sequencing

Research Paper|Volume 16, Issue 6|pp. 5676–5702

Identification and validation of a novel signature based on macrophage marker genes for predicting prognosis and drug response in kidney renal clear cell carcinoma by integrated analysis of single cell and bulk RNA sequencing

Back to articleFigure 10(10 of 12)

100%

Figure 10.Drug sensitivity analysis. The comparisons in IC50 of AKT inhibitor (A), Axitinib (B), Gefitinib (C), Pazopanib (D), Crizotinib (E), and Cisplatin (F) between the two risk groups.